相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Francesco Schettini et al.
NPJ BREAST CANCER (2021)
Association between Lymph Node Status and Expression Levels of Androgen Receptor, miR-185, miR-205, and miR-21 in Breast Cancer Subtypes
Tatiana S. Kalinina et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2020)
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy
Gines Luengo-Gil et al.
CELLULAR ONCOLOGY (2019)
miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer
Yuanyuan Zong et al.
BIOSCIENCE REPORTS (2019)
The emerging role of CDK4/6i in HER2-positive breast cancer
Ciara C. O'Sullivan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
mirDIP 4.1-integrative database of human microRNA target predictions
Tomas Tokar et al.
NUCLEIC ACIDS RESEARCH (2018)
Down-regulation of microRNA-19b in hormone receptor-positive/HER2-negative breast cancer
Elham Maleki et al.
APMIS (2018)
Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis
Runting Yin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway
Chuansheng Li et al.
ONCOTARGETS AND THERAPY (2018)
Increased expression of miR-155 and miR-222 is associated with lymph node positive status
Vladimir Chernyy et al.
JOURNAL OF CANCER (2018)
Mechanisms for estrogen receptor expression in human cancer
Hui Hua et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes
Sasagu Kurozumi et al.
JOURNAL OF HUMAN GENETICS (2017)
MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer
Song-Hee Han et al.
JOURNAL OF BREAST CANCER (2017)
被撤回的出版物: MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1 (Retracted article. See vol. 22, 2021)
Quanqing Zou et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
MicroRNA regulation of progesterone receptor in breast cancer
Avital Gilam et al.
ONCOTARGET (2017)
Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
Ling Deng et al.
ONCOTARGET (2017)
Cancer prevention from the perspective of global cancer burden patterns
Hiroki Nagai et al.
JOURNAL OF THORACIC DISEASE (2017)
The Dual Regulatory Role of MiR-181a in Breast Cancer
Chun Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Receptor conversion in metastatic breast cancer: a prognosticator of survival
Meng Xiangying et al.
ONCOTARGET (2016)
HER2+Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B
Daniel C. Kirouac et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer
Bo Chen et al.
CANCER LETTERS (2015)
Analysis of the miRNA-mRNA-lncRNA networks in ER plus and ER- breast cancer cell lines
Qian Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Progesterone receptor expression in granulosa cells is suppressed by microRNA-378-3p
Derek Toms et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
miR-20b is up-regulated in brain metastases from primary breast cancers
Aamir Ahmad et al.
ONCOTARGET (2015)
miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A
Kazuhiro Ikeda et al.
SCIENTIFIC REPORTS (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
MiRNA Expression in Breast Cancer Varies with Lymph Node Metastasis and Other Clinicopathologic Features
Bin Wang et al.
IUBMB LIFE (2014)
High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
Simone Anfossi et al.
PLOS ONE (2014)
Pathogenesis, prevention, diagnosis and treatment of breast cancer
Rupen Shah et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Distinguishing Score 0 From Score 1+in HER2 Immunohistochemistry-Negative Breast Cancer Clinical and Pathobiological Relevance
Kathleen Lambein et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
S.M. Donnelly et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival
Yuyang Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
Ji-Yu Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Endometrial miR-181a and miR-98 Expression Is Altered during Transition from Normal into Cancerous State and Target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3
Harekrushna Panda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer
Nobuyasu Yoshimoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Estrogen Induces c-myc Gene Expression via an Upstream Enhancer Activated by the Estrogen Receptor and the AP-1 Transcription Factor
Chunyu Wang et al.
MOLECULAR ENDOCRINOLOGY (2011)
The Timing of the Age at Which Natural Menopause Occurs
Ellen B. Gold
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2011)
TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer
Susanna Stinson et al.
SCIENCE SIGNALING (2011)
miR-378☆ Mediates Metabolic Shift in Breast Cancer Cells via the PGC-1β/ERRγ Transcriptional Pathway
Lillian J. Eichner et al.
CELL METABOLISM (2010)
An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples
Jianhua Xiong et al.
FEBS JOURNAL (2010)
miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA
Deo Prakash Pandey et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response
Leandro Castellano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer
Naoto Kondo et al.
CANCER RESEARCH (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter
L Cicatiello et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The role of steroid hormones on the regulation of vascular endothelial growth factor
SM Hyder
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
